Artwork

Content provided by John Lynn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by John Lynn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How AI is Shaping Drug Discovery at AION Labs

37:21
 
Share
 

Manage episode 419229692 series 3255313
Content provided by John Lynn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by John Lynn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In the fast-paced realm of pharmaceuticals, where innovation can mean the difference between life and death, the integration of artificial intelligence (AI) is reshaping the landscape of drug discovery and development. Mati Gill, CEO at AION Labs, stands at the forefront of this revolution, pioneering the use of AI to tackle the challenges inherent in the pharma industry. With a unique combination of expertise in AI and pharmaceuticals, Gill leads AION Labs in its mission to harness the power of technology for the greater good. In our recent video interview, he shared insights into how AI is transforming drug discovery, emphasizing the need for innovation in an industry marked by complexity and high stakes. Learn more about AION Labs: https://aionlabs.com/ Health IT Community: https://www.healthcareittoday.com/

  continue reading

546 episodes

Artwork
iconShare
 
Manage episode 419229692 series 3255313
Content provided by John Lynn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by John Lynn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In the fast-paced realm of pharmaceuticals, where innovation can mean the difference between life and death, the integration of artificial intelligence (AI) is reshaping the landscape of drug discovery and development. Mati Gill, CEO at AION Labs, stands at the forefront of this revolution, pioneering the use of AI to tackle the challenges inherent in the pharma industry. With a unique combination of expertise in AI and pharmaceuticals, Gill leads AION Labs in its mission to harness the power of technology for the greater good. In our recent video interview, he shared insights into how AI is transforming drug discovery, emphasizing the need for innovation in an industry marked by complexity and high stakes. Learn more about AION Labs: https://aionlabs.com/ Health IT Community: https://www.healthcareittoday.com/

  continue reading

546 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide